Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

17.09 +0.48 (+2.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,389,219
Open 16.65
Bid (Size) 17.10 (1)
Ask (Size) 17.16 (2)
Prev. Close 16.61
Today's Range 16.61 - 17.20
52wk Range 13.10 - 26.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Applied Materials To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
Super League, Terawulf, Cellebrite Dominate Stocktwits Retail Chatter Among Tech Stocks: Find Out Why
Via Stocktwits

Performance

YTD
-21.1%
-21.1%
1 Month
+25.9%
+25.9%
3 Month
+2.8%
+2.8%
6 Month
+1.8%
+1.8%
1 Year
+4.1%
+4.1%

More News

Read More
Cellebrite Reports 21 Percent ARR Growth
Via The Motley Fool
Cellebrite Begins Its Next Chapter
Via The Motley Fool
Cellebrite DI Ltd (NASDAQ:CLBT) Posts Mixed Q2 2025 Earnings Amid Leadership Changes and Strategic Moves
Via Chartmill
Earnings Scheduled For August 14, 2025
Via Benzinga
Is This Stock a Next-Gen Digital Forensics Leader?
Via The Motley Fool
Earnings Scheduled For February 13, 2025
Via Benzinga
Cellebrite Announces Second-Quarter 2025 Results
From Cellebrite DI Ltd
Via GlobeNewswire
U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Names David Barter Chief Financial Officer
From Cellebrite DI Ltd
Via GlobeNewswire
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
From Cellebrite DI Ltd
Via GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Cellebrite to Acquire Corellium
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Participation in Upcoming Investor Conferences
From Cellebrite DI Ltd
Via GlobeNewswire
Dow Edges Higher; US Crude Oil Inventories Increase
Via Benzinga
Topics Stocks
Cellebrite Announces First-Quarter 2025 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations
From Cellebrite DI Ltd
Via GlobeNewswire
Earnings Scheduled For May 14, 2025
Via Benzinga
Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025
From Cellebrite DI Ltd
Via GlobeNewswire
10 Winners Awarded “Justies” at Cellebrite’s First-Ever Digital Justice Awards
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Files its 2024 Annual Report on Form 20-F
From Cellebrite DI Ltd
Via GlobeNewswire
5 Technology Names That Saw Brisk Retail Activity On Stocktwits Last Week
Via Stocktwits
The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs
Via Talk Markets
Topics Stocks Stocks / Equities
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire

Frequently Asked Questions

Is Cellebrite DI Ltd. - Ordinary Shares publicly traded?
Yes, Cellebrite DI Ltd. - Ordinary Shares is publicly traded.
What exchange does Cellebrite DI Ltd. - Ordinary Shares trade on?
Cellebrite DI Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cellebrite DI Ltd. - Ordinary Shares?
The ticker symbol for Cellebrite DI Ltd. - Ordinary Shares is CLBT on the Nasdaq Stock Market
What is the current price of Cellebrite DI Ltd. - Ordinary Shares?
The current price of Cellebrite DI Ltd. - Ordinary Shares is 17.09
When was Cellebrite DI Ltd. - Ordinary Shares last traded?
The last trade of Cellebrite DI Ltd. - Ordinary Shares was at 09/08/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.